Loading…
Inhaled beclomethasone dipropionate downregulates CD4 and CD8 T-lymphocyte activation in peripheral blood of patients with asthma
Background: Previous studies demonstrated a downregulation of T-lymphocyte (CD3 + cells) activation in peripheral blood after treatment with inhaled corticosteroids in patients with asthma. Objective: This study was carried out to evaluate the effect of inhaled corticosteroids on CD4 + and CD8 + T-l...
Saved in:
Published in: | Journal of allergy and clinical immunology 1997-09, Vol.100 (3), p.379-382 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background: Previous studies demonstrated a downregulation of T-lymphocyte (CD3
+ cells) activation in peripheral blood after treatment with inhaled corticosteroids in patients with asthma.
Objective: This study was carried out to evaluate the effect of inhaled corticosteroids on CD4
+ and CD8
+ T-lymphocyte activation, respectively.
Methods: We examined the expression of three surface activation markers (CD25, HLA-DR, and very late activation antigen 1) on circulating CD4
+ and CD8
+ T-cell subsets in subjects with asthma (
n = 23) before and 8 weeks after treatment with inhaled beclomethasone dipropionate dry powder (daily dose, 800 μg).
Results: Beclomethasone dipropionate treatment had a marked effect in reducing the expression of the activation marker CD25 (
p < 0.01) in both CD4
+ and CD8
+ T-cell subsets in peripheral blood of patients with asthma. However, no correlation was found between the downregulation of CD4
+ and CD8
+ T-lymphocyte activation and the improvement in physiologic indices of disease activity.
Conclusions: These data add to the view that CD4
+ and CD8
+ T lymphocytes in peripheral blood of patients with asthma are in an activated state that is downregulated by inhaled corticosteroids. (J Allergy Clin Immunol 1997;100:379-82.) |
---|---|
ISSN: | 0091-6749 1097-6825 |
DOI: | 10.1016/S0091-6749(97)70252-5 |